No abstract available
MeSH terms
-
Adult
-
Antibodies, Monoclonal / therapeutic use
-
Chronic Disease
-
Cohort Studies
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Humans
-
Injections, Subcutaneous
-
Male
-
Middle Aged
-
Omalizumab / therapeutic use*
-
Prognosis
-
Recurrence
-
Retreatment
-
Retrospective Studies
-
Risk Assessment
-
Severity of Illness Index
-
Treatment Outcome
-
Urticaria / diagnosis*
-
Urticaria / drug therapy*
Substances
-
Antibodies, Monoclonal
-
Omalizumab